Popular Brachytherapy News and Current Events | Page 6

Popular Brachytherapy News and Current Events, Brachytherapy News Articles.
Sort By: Most Relevant | Most Recent
Page 6 of 6 | 224 Results
Agent Orange exposure increases veterans' risk of aggressive recurrence of prostate cancer
Veterans exposed to Agent Orange are at increased risk of aggressive recurrence of prostate cancer, researchers report. (2009-04-20)

High-dose radiation treatment effective at fighting some cancers in children
Directing high-level doses of radiation at malignant tumors during surgery shows promise in treating certain childhood cancers. Eleven of 13 children in an Ohio State University study remained cancer-free an average of four years after treatment with a technique called intraoperative high-dose-rate brachytherapy (IO-HDRBT). Ten of the surviving children were treated during advanced stages of their diseases. (2001-12-12)

Irradiated balloons may help prevent plaque re-growth in blocked arteries
Cardiologists at Cedars-Sinai Medical Center in Los Angeles are participating in a randomized clinical trial studying the use of irradiated balloons to help prevent blocked arteries from developing recurring blockages. The procedure, known as intracoronary brachytherapy, was approved by the FDA in July and is designed to prevent re-growth of scar tissue after an arterial blockage has been removed with the use of angioplasty and stent. (2001-09-25)

Researchers develop and test new molecule as a delivery vehicle to image and kill brain tumors
A single compound with dual function -- the ability to deliver a diagnostic and therapeutic agent -- may one day be used to enhance the diagnosis, imaging and treatment of brain tumors, according to findings from Virginia Commonwealth University and Virginia Tech. (2011-08-03)

CREST study finds cilostazol reduces restenosis by almost 40 percent
A new and highly effective weapon in the war on heart disease could be on the horizon, according to results of the (2003-11-09)

Combining radiation modalities increases
High-risk prostate cancer patients who undergo a combination of hormonal therapy, radioactive seed implant (also called brachytherapy) and external beam radiation therapy are shown to have an increased chance of cancer cure, according to a new study by researchers at Mount Sinai School of Medicine published in the August 1, 2004, issue of the International Journal of Radiation Oncology*Biology*Physics. (2004-07-29)

Jefferson radiation oncologists use real-time system to plant 'seeds' against cancer
Radiation oncologists and urologists at the Kimmel Cancer Center at Jefferson have begun using a real-time system to implant radiation-emitting seeds in prostate cancer patients. While the system is only being used for imaging and planning so far, it ultimately will help in placing the seeds. The team hopes that the technology will make a good system even better, adding scientific precision to a treatment that currently relies mainly on physician experience and skill. (2007-09-21)

Researchers find risk markers for erectile dysfunction following radiation in prostate cancer
In the first study of its kind, a research team led by Mount Sinai School of Medicine and Albert Einstein College of Medicine of Yeshiva University discovered 12 genetic markers associated with the development of erectile dysfunction in prostate cancer patients who were treated with radiation. (2012-09-27)

Prostate size and other neglected factors influence prostate cancer treatment satisfaction
Men with prostate cancer and their partners face difficult decisions regarding treatment, and accurate information regarding expected outcomes can be hard to find, according to results of a multicenter study published Wednesday in the New England Journal of Medicine. (2008-03-19)

New advance in radiation therapy may improve cancer treatment
At an international conference in Chicago, medical physicists will describe an innovative new technique known as (2000-07-18)

New clinical program development fund awards $17.6 million in grants for Yale-New Haven Medical Center
New research at Yale in cancer, brain disorders, cardiovascular disease, developmental disorders and organ transplantation will be advanced with $17.6 million in grants from the New Clinical Program Development Fund (the Fund). (2001-05-09)

Ultrasound Imaging Advance Improves Prostate Cancer Treatment
Assessing whether prostate cancer patients are eligible for radioactive seed implantation therapy, a preferred new treatment, can now be made in minutes rather than days, and at a fraction of the usual cost, using a new ultrasound imaging technology developed by researchers at the University of Washington and Seattle Prostate Institute. (1998-08-04)

Mount Sinai Researchers present findings on treatments for prostate and breast cancer
Researchers from the Department of Radiation Oncology and the Milton and Caroll Petrie Department of Urology at Mount Sinai School of Medicine are presenting findings from ten studies of prostate and breast cancer treatments at the 47th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), October 16-20, 2005, in Denver, Colorado. (2005-10-18)

PNNL wins prestigious R&D 100 awards for five technologies
Pacific Northwest National Laboratory has been recognized with five 2006 R&D 100 awards for a new cancer treatment method, a process that reduces the rate of post-surgical infection, and technologies that have reduced energy use, and led to improvements in the health and materials fields. (2006-07-07)

Study finds side effects, complications, mastectomy more likely after partial breast irradiation
Accelerated partial breast irradiation brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate of later mastectomy, increased radiation-related toxicities and post-operative complications, compared to traditional whole breast irradiation, according to researchers from the University of Texas MD Anderson Cancer Center. (2011-12-06)

Emory scientists find oral tetrahydrobiopterin can reduce high blood pressure
In a presentation at the AHA's Scientific Sessions here today, Sonya Lefever, MD, a senior cardiology fellow at Emory, discussed findings by Emory researchers suggesting that oral tetrahydrobiopterin (also known as BH4) holds promise as a therapy for patients with hypertension. BH4 is an essential co-factor needed in the body for the synthesis of nitric oxide (NOS). (2003-11-11)

Long-term outcomes for prostate cancer show IMRT Curative: 89 percent disease-free 8 years later
Results from the largest study of men with prostate cancer treated with high-dose, intensity modulated radiation therapy (IMRT) show that the majority of patients remain alive with no evidence of disease after an average follow-up period of eight years. (2006-09-27)

3-week course of breast radiation may be as effective as conventional 5- to 7-week course for early breast cancers
According to a study presented Nov. 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology, a shortened, more intensive course of radiation given to the whole breast, along with an extra dose of radiation given to the surgical bed of the tumor (concomitant boost), has been shown to result in excellent local control at a median follow up of two years after treatment with no significant sides effects. (2009-11-04)

May 2005 Ophthalmology journal
Studies from the May 2005 issue of Ophthalmology, the clinical journal of the American Academy of Ophthalmology, are now available. (2005-05-01)

Advanced, precise radiation may boost limb-sparing therapy for sarcoma
Brachytherapy holds promise as part of a limb-sparing treatment program for patients with soft-tissue sarcomas, according to researchers at the Keck School of Medicine of USC. (2004-11-02)

Successful prostate surgery: It's quality of surgery not quantity that matters most
Research presented at ECCO 12 - The European Cancer Conference shows that a surgeon's personal skill in performing radical prostate surgery and not necessarily the number of operations performed is the key to a patient's future quality of life and the potential for a cure. (2003-09-22)

Study shows radiation device may customize therapy, enable some to avoid more lengthy treatment
A study of the first approximately 100 patients who have received partial breast irradiation with a small, whisk-like, expandable device inserted inside the breast has shown that after one year, the device is effective at sparing nearby healthy tissue from the effects of radiation. The device, called SAVI, is aimed at providing customized radiation therapy while minimizing exposure to healthy tissue around the breast after a woman has received a lumpectomy for early stage cancer. (2008-09-24)

Study shows seed implants a suitable prostate cancer treatment option for men of all ages
Men diagnosed with prostate cancer have a number of treatments to choose from, but it's a daunting task to figure out the right mix of therapies for an individual patient. Trends among medical professionals have tipped the scales in favor of some treatments for younger men diagnosed with prostate cancer. The Feinstein Institute for Medical Research and North Shore-LIJ Health System have found that age doesn't make a difference in the long-term therapeutic outcome. (2009-08-03)

Quality of life continues to change long-term after treatment for prostate cancer
Four to eight years after men undergo treatment for prostate cancer, they continue to see changes - both positive and negative - in their quality of life because of that treatment, researchers at the University of Michigan Health System and Harvard Medical School report. (2004-05-10)

Page 6 of 6 | 224 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.